HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Aman U Buzdar Selected Research

Aman U Buzdar Research Topics

Disease

112	Breast Neoplasms (Breast Cancer) 07/2015 - 01/2002
49	Neoplasms (Cancer) 01/2015 - 01/2002
15	Carcinoma (Carcinomatosis) 06/2006 - 11/2002
8	Neoplasm Metastasis (Metastasis) 05/2012 - 08/2002
5	Endometrial Neoplasms (Endometrial Cancer) 02/2008 - 12/2002
4	Hemorrhage 02/2008 - 12/2002
4	Residual Neoplasm 01/2007 - 04/2004
3	Disease Progression 02/2010 - 05/2004
2	Exanthema (Rash) 04/2015 - 01/2013
2	Neutropenia 01/2011 - 02/2010
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2011 - 01/2007
2	Obesity 09/2008 - 09/2008
2	Lobular Carcinoma 11/2006 - 01/2005
2	Inflammatory Breast Neoplasms 03/2006 - 02/2004
2	Heart Failure 06/2005 - 11/2002
1	Anemia 07/2011
1	Infection 01/2011
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Arthritis (Polyarthritis) 09/2008
1	Arthralgia (Joint Pain) 09/2008
1	Hot Flashes 02/2008
1	Colorectal Neoplasms (Colorectal Cancer) 02/2008
1	Bone Resorption 02/2008
1	Osteoporosis 01/2008
1	Nausea 11/2007
1	Vaginal Discharge 11/2007
1	Ductal Carcinoma 01/2005
1	Radiation Pneumonitis (Radiation Fibrosis) 11/2004
1	Pneumonia (Pneumonitis) 11/2004
1	Colitis 10/2004
1	Abdominal Pain (Pain, Abdominal) 10/2004
1	Hyperplasia 09/2004

Drug/Important Bio-Agent (IBA)

32	Tamoxifen FDA LinkGeneric 05/2013 - 01/2002
28	Estrogens (Estrogen)FDA Link 07/2015 - 01/2002
27	HormonesIBA 01/2015 - 10/2002
25	anastrozole (Arimidex)FDA LinkGeneric 07/2015 - 06/2002
21	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013 - 01/2002
21	Paclitaxel (Taxol)FDA LinkGeneric 12/2013 - 04/2002
20	Fluorouracil (Carac)FDA LinkGeneric 12/2013 - 01/2002
19	Aromatase InhibitorsIBA 04/2012 - 11/2002
18	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2011 - 01/2002
15	trastuzumab (Herceptin)FDA Link 01/2015 - 06/2005
12	letrozole (Femara)FDA LinkGeneric 05/2007 - 11/2002
11	Progesterone Receptors (Progesterone Receptor)IBA 05/2013 - 10/2002
9	Epidermal Growth Factor Receptor (EGF Receptor)IBA 04/2015 - 10/2002
8	exemestane (Aromasin)FDA Link 09/2008 - 01/2003
7	Epirubicin (Ellence)FDA LinkGeneric 12/2013 - 06/2005
6	Aromatase (CYP19)IBA 05/2013 - 12/2002
5	taxaneIBA 07/2011 - 10/2004
5	fulvestrant (Faslodex)FDA Link 09/2008 - 01/2003
5	Estrogen ReceptorsIBA 02/2006 - 05/2002
5	Megestrol Acetate (Borea)FDA LinkGeneric 01/2004 - 11/2002
4	TaxoidsIBA 12/2009 - 01/2003
4	AnthracyclinesIBA 12/2009 - 01/2003
3	Selective Estrogen Receptor Modulators (SERM)IBA 09/2013 - 01/2008
3	Estrogen Receptor Modulators (Antiestrogen)IBA 02/2006 - 01/2003
2	lapatinib (GW572016)FDA Link 04/2015 - 01/2013
2	Biological Markers (Surrogate Marker)IBA 05/2013 - 02/2012
2	DNA (Deoxyribonucleic Acid)IBA 04/2013 - 03/2011
2	docetaxel (Taxotere)FDA Link 05/2012 - 03/2012
2	capecitabine (Xeloda)FDA Link 03/2012 - 03/2008
2	Messenger RNA (mRNA)IBA 11/2011 - 01/2007
2	Biological Tumor Markers (Tumor Markers)IBA 10/2010 - 01/2008
2	Epothilones (Epothilone)IBA 03/2008 - 12/2007
2	LY 353381 (LY353381)IBA 01/2008 - 11/2007
2	thymidine 5'-triphosphate (TTP)IBA 09/2004 - 05/2004
1	Sirolimus (Rapamycin)FDA Link 05/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2013
1	Epidermal Growth Factor (EGF)IBA 05/2013
1	Estradiol (Estrace)FDA LinkGeneric 04/2013
1	N 30IBA 05/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2012
1	MicroRNAs (MicroRNA)IBA 05/2012
1	Carboplatin (JM8)FDA LinkGeneric 05/2012
1	HematinicsIBA 07/2011
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2011
1	albumin-bound paclitaxel FDA Link 02/2010
1	hydroquinone (Black and White)FDA Link 10/2008
1	Growth Factor ReceptorsIBA 09/2008
1	sagopiloneIBA 03/2008
1	ixabepilone (BMS 247550)FDA Link 03/2008
1	desoxyepothilone B (epothilone D)IBA 03/2008
1	epothilone B (EPO906)IBA 03/2008
1	Antineoplastic Agents (Antineoplastics)IBA 12/2007
1	erbB-2 Receptor (Receptor, erbB 2)IBA 02/2007
1	Trientine (Trien)FDA Link 02/2006
1	Dihydrotachysterol (AT 10)IBA 10/2005
1	SteroidsIBA 11/2004
1	Toremifene (Fareston)FDA Link 09/2004

Therapy/Procedure

65	Drug Therapy (Chemotherapy) 12/2013 - 01/2002
10	Neoadjuvant Therapy 12/2013 - 10/2002
10	Adjuvant Chemotherapy 01/2013 - 01/2002
8	Mastectomy (Mammectomy) 07/2006 - 01/2002
7	Radiotherapy 07/2006 - 07/2002
2	Segmental Mastectomy (Lumpectomy) 09/2006 - 10/2002
2	Aftercare (After-Treatment) 10/2004 - 02/2004
1	Lymph Node Excision (Lymph Node Dissection) 06/2010
1	Combined Modality Therapy 12/2008
1	Oral Administration 02/2006
1	Heterologous Transplantation (Xenotransplantation) 01/2005